Online citations, reference lists, and bibliographies.
← Back to Search

The Hematopoietic And Epithelial Forms Of CD44 Are Distinct Polypeptides With Different Adhesion Potentials For Hyaluronate‐bearing Cells.

I. Stamenković, A. Aruffo, M. Amiot, B. Seed
Published 1991 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
CD44 is a polymorphic integral membrane protein which recognizes hyaluronate and whose proposed roles encompass lymphocyte activation, matrix adhesion and the attachment of lymphocytes to lymph node high endothelial venules (HEVs). Immunochemical and RNA blot data have supported the existence of two forms of CD44: a hematopoietic form expressed by cells of mesodermal origin (and by some carcinoma cell lines) and an epithelial form weakly expressed by normal epithelium but highly expressed by carcinomas. This report describes the isolation of a cDNA encoding a distinct CD44 polypeptide expressed by epithelial cells. Re‐expression of each form of CD44 in a B cell line allowed cells transfected with the hematopoietic but not the epithelial form to bind to viable rat lymph node HEV cells in primary culture.



This paper is referenced by
10.1016/0959-8049(95)00452-1
Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells.
H. Orzechowski (1995)
10.1136/mp.50.2.57
CD44 and the adhesion of neoplastic cells.
Z. Rudzki (1997)
10.1038/nm0695-558
Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis
K. Mikecz (1995)
10.1083/JCB.120.1.227
A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps
K. H. Heider (1993)
10.1016/0142-9612(93)90160-4
Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats.
L. Benedetti (1993)
10.1016/0959-8049(93)90442-I
CD44 and its role in tumour progression and metastasis.
J. East (1993)
10.1038/KI.1996.195
Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum.
H. Fricke (1996)
10.1074/JBC.271.16.9490
Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate (*)
K. Takahashi (1996)
10.1083/JCB.134.4.1075
CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma
R. Clark (1996)
10.1016/S0002-9440(10)65666-0
Multiple intron retention occurs in tumor cell CD44 mRNA processing.
S. Goodison (1998)
10.1046/j.1365-2559.1998.00262.x
Current status of CD44 variant isoforms as cancer diagnostic markers
Goodison (1998)
10.1007/0-306-46817-4_11
Adhesion molecules in cancer biology.
Y. Ohene-Abuakwa (2000)
10.14201/gredos.76575
Cáncer de colon experimental: caracterización del modelo mediante marcadores tumorales y moléculas de adhesión
Fernando Roux Carmona (2009)
10.3109/15419060009015004
The CD44 Receptor of Lymphoma Cells: Structure-Function Relationships and Mechanism of Activation
M. Rochman (2000)
10.1002/IJC.2910640307
Expression of cd44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential
E. Manten-Horst (1995)
10.1053/EJSO.2001.1167
The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
S. Morris (2001)
10.1007/s10875-007-9128-5
Alteration of the Expression of CD4 Isoforms in Oral Epithelia and Saliva from Patients with Oral Lichen Planus
P. Chaiyarit (2007)
CD 44 cell adhesion molecules
S. Goodison (1999)
10.1111/1523-1747.EP12614896
The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44.
L. C. Kugelman (1992)
10.1007/BF00717001
Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages
C. Wang (2004)
10.1007/978-1-4615-6405-8
Targeting of Drugs 5
G. Gregoriadis (1996)
10.1007/BF00182053
Proteoglycans and glycosaminoglycans in tumor growth and migration: first experience with tumors of bladder and prostate origin
D. Schamhart (2004)
10.1002/BIES.950170106
CD44 isoforms during differentiation and development
P. Ruiz (1995)
10.1016/1074-7613(94)90103-1
A regulatory role for recombinase activating genes, RAG-1 and RAG-2, in T cell development.
J. Wayne (1994)
Proteins CD 44 : Analysis Using CD 44-Fas Chimeric Requirements for Signal Delivery Through
H. Ishiwatari-Hayasaka (1999)
10.1186/s12885-020-06753-0
Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
J. Shi (2020)
10.1093/emboj/20.15.4194
Regulation of alternative pre‐mRNA splicing by the ERK MAP‐kinase pathway
S. Weg-Remers (2001)
10.1023/A:1005760726850
Molecular and cellular pathology of intrinsic brain tumours
Abderrahim Merzak (2004)
10.1083/JCB.131.6.1623
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
K. Bennett (1995)
10.1016/S1386-6346(97)00102-2
Serum soluble CD44 levels in patients with acute and fulminant hepatitis
K. Suzuki (1998)
10.1046/J.1523-1747.1998.00302.X
Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
S. Wagner (1998)
CD44 function as a growth factor co-receptor
L. Chen (2003)
See more
Semantic Scholar Logo Some data provided by SemanticScholar